Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

Author： Mohammed M.Q.   Abraha H.D.   Sherwood R.A.   MacRae K.   Retsas S.  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.18, Iss.2, 2001-03, pp. : 109-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma

By Banfalvi T.   Gilde K.   Gergye M.   Boldizsar M.   Kremmer T.   Otto S.  

European Journal of Cancer, Vol. 39, Iss. 2, 2003-01 ,pp. : 164-169

Elsevier

Access to resources Recommend Favorite

S-100β Protein – Serum Levels in Children with Brain Neoplasms and its Potential as a Tumor Marker

By Rajendra Anil   Spinella Philip   Drott Henry   Dominguez Troy   Sutton Leslie   Helfaer Mark  

Journal of Neuro-Oncology, Vol. 67, Iss. 3, 2004-05 ,pp. : 345-349

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Serum S100 in Metastatic Malignant Melanoma

By Hua B.G.   Stoffel-Wagner B.   Bierwirth T.   Mezger J.   Klingmuller D.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1898-1902

Elsevier

Access to resources Recommend Favorite

Clinical significance of serum S100 in metastatic malignant melanoma

By Guo H.B.   Stoffel-Wagner B.   Bierwirth T.   Mezger J.   Klingmuller D.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 924-928

Elsevier

Access to resources Recommend Favorite

Serum VEGF-C is associated with metastatic site in patients with malignant melanoma

By Vihinen Pia P.   Hilli Johanna   Vuoristo Meri-Sisko   Syrjänen Kari J.   Kähäri Veli-Matti   Pyrhönen Seppo O.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 678-684

Informa Healthcare

Access to resources Recommend Favorite